The effect of sympathomimetic medication on cardiovascular functioning of children with attention-deficit/hyperactivity disorder

Cardiovascular Journal of Africa

Volumn 20, Issue 5, 2009, Pages 296-299

  Negrao, Bianca Lee ^a   Crafford, Dalene ^a   Viljoen, Margaretha ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; METHYLPHENIDATE;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; BLOOD PRESSURE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISPERSION; DRUG EFFICACY; DRUG SAFETY; DRUG USE; ELECTROCARDIOGRAM; FEMALE; HEART RATE; HEART RATE VARIABILITY; HEART SOUND RECORDER; HUMAN; HYPERTENSION; MALE; MERCURY SPHYGMOMANOMETER; OUTCOME ASSESSMENT; PRESCHOOL CHILD; QT INTERVAL; REST; SCHOOL CHILD; SIDE EFFECT; SPHYGMOMANOMETER; STETHOSCOPE; TREATMENT DURATION;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BLOOD PRESSURE; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; MALE; METHYLPHENIDATE; SYMPATHOMIMETICS;

EID: 70449944914     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Wooltorton E. Medications for attention deficit hyperactivity disorder: cardiovascular concerns. Can Med Assoc J 2006; 175(1): 29-30. (Pubitemid 44065184)
2. Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Harpold T, et al. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 2006; 59: 829-835.
3. Biederman J, Baldessarini RJ, Wright V, Knee D, Harmatz JS, Goldblatt A. A double-blind placebo controlled study of desipramine in the treatment of ADD: II Serum drug levels and cardiovascular findings. J Am Acad Child Adolesc Psychiatry 1989; 28(6): 903-911. (Pubitemid 20031025)
4. Wernicke JF, Faries D, Girod D, Brown J, Gao H, Kelsey D, et al. Cardiovascular effects of atomoxetine in children, adolescents and adults. Drug Saf 2003; 26(10): 729-740. (Pubitemid 36976134)
5. Ballard JE, Boileau RA, Sleator EK, Massey BH, Sprague RL. Cardiovascular responses of hyperactive children to methylphenidate. J Am Med Assoc 1976; 236(25) 2870-2874.
6. Spencer TJ, Adler LA, McGough JJ, Muniz R, Jiang H, Pestreich L, et al. Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 2007; 61: 1380-1387. (Pubitemid 46855767)
7. Vetter VL, Elia J, Erickson C, Berger S, Blum N, Uzark K, et al. Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs: A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing. Circulation 2008; 117: 2407-2423. (Pubitemid 351653546)
8. Biederman J, Boellner SW, Childress A, Lopez FA, Krishnan S, Zhang Y. Lisdexamfetamine dimesylate and mixed amphetamine salts extended release in children with ADHD: A double-blind, placebo-controlled, crossover analog classroom study. Biol Psychiatry 2007; 62: 970-976. (Pubitemid 47562371)
9. Prasad S, Furr AJ, Zhang S, Ball S, Allen AJ. Baseline values from the electrocardiograms of children and adolescents with ADHD. Child Adoles Psychiat Mental Hlth 2007; 1.11: 11. (Pubitemid 351833739)
10. Wernicke JF, Kratochvil CJ. Safety profile of atomoxetine in the treatment of children and adolescents with ADHD. J Clin Psychiatry 2002; 63(Suppl 12): 50-55.
11. Simpson D, Plosker GL. Spotlight on atomoxetine in adults with attention- deficit hyperactivity disorder. CNS Drugs 2004; 18(6): 397-401.
12. Ilgenli TF, Congologlu AO, Cengiz TT, Akpinar O, Kilicaslan F. Acute effect of methylphenidate on QT interval duration and dispersion in children with attention deficit hyperactivity disorder. Adv Ther 2007; 24(1): 182-188. (Pubitemid 46700878)
13. Hughes S, Barclay L. Children with ADHD should have ECG before taking stimulant drugs. Medscape Med News April 22, 2008.
14. Wernicke JF, Faries D, Breitung R, Girod D. QT correction methods in children and adolescents. J Cardiovasc Electrophysiol 2005; 16(1): 76-81.
15. Crow RS, Hannan PJ, Folsom AR. Prognostic significance of corrected QT and corrected JT interval for incident coronary heart disease in a general population sample stratified by presence or absence of wide QRS complex: The ARIC study with 13 years of follow-up. Circulation 2003; 1985-1989.
16. Salim MA, Case CL, Gillette PC. The JT interval as a depolarization independent measurement of repolarization. Pacing Clin Electrophysiol 1995; 18(12): 2158-2162.
17. Čorović N, Duraković Z, Mišigoj- Duraković M. Dispersion of the corrected QT and JT interval in the electrocardiogram of alcoholic patients. Alcohol Clin Exp Res 2006; 30(1): 150-154. (Pubitemid 43341408)
18. Lanjewar P, Pathak V, Lokhandwala Y. Issues in QT interval measurement. Ind Pacing Electrophysiol J 2004; 4(4): 156-161.
19. Berul CI, Sweeten TL, Dubin AM, Shah MJ, Vetter VL. Use of the rate-corrected JT interval for prediction of repolarization abnormalities in children. Am J Cardiol 1994; 74: 1254-1257. (Pubitemid 24375018)
20. Djoussé L, Rautaharju PM, Hopkins PN, Whitsel EA, Arnett DK, Eckfeldt JH, et al. Dietary linolenic acid and adjusted QT and JT intervals in the National Heart, Lung, and Blood Institute Family Heart Study. J Am Coll Cardiol 2005; 45(10): 1716-1722. (Pubitemid 40704511)
21. Nahshoni E, Spitzer S, Berant M, Shoval G, Zalsman G, Weizman A. QT interval and dispersion in very young children treated with antipsychotic drugs: a retrospective chart review. J Child Adolesc Psychopharmacol 2007; 17(2): 187-194. (Pubitemid 46828914)
22. Statters DJ, Malik M, Ward DE, Camm AJ. QT dispersion: problems of methodology and clinical significance. J Cardiovasc Electrophysiol 1994; 5(8): 672-685. (Pubitemid 24278192)
23. Zaidi M, Robert A, Fesler R, Derwael C, Brohet C. Dispersion of ventricular repolarisation: a marker of ventricular arrythmias in patients with previous myocardial infarction. Heart 1997; 78: 371-375. (Pubitemid 27479639)
24. Glancy JM, Woods KL, de Bono DP. QT Dispersion and prognosis after myocardial infarction. J Am Coll Cardiol 1995; 25(2) Suppl 1: 7A.
25. Grant CC. Heart rate variability and dysrhythmogenic potential in patients admitted to psychiatric institutions [dissertation]. Pretoria: University of Pretoria, 2005.